The items that Amphastar must produce on or before 10/17/11 include the following sections of Amphastar’s ANDA: i) release testing related to detecting 1,6-anhydro ring structures; ii) release testing related to sequencing of tetrasaccharides; and ii) master batch records. What is the likely scenario if / when Momenta complains and the court agrees that the items were not provided as requested?